| 000 | 018990000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223030254.0 | ||
| 008 | 061220s2005 ua f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2005.Da.D | ||
| 100 | 0 | _aDalia Ahmed Hamed Aly | |
| 245 | 1 | 0 |
_aDetermination of serum levels of Malondialdehyde and Ceruloplasmin in HCV patients / _cDalia Ahmed Hamed Aly ; Supervised Mona Salem Khalil , Marian Fathi Eshak , Rasha Ahmed Abd El aziz |
| 246 | 1 | 5 | _aقياس مستوى مالونداىالدهايد وسيريلوبلازمين فى مصل الدم فى مرضى التهاب الكبد الوبائى سى |
| 260 |
_aCairo : _bDalia Ahmed Hamed Aly , _c2005 |
||
| 300 |
_a112P ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Clinical and Chemical Pathology | ||
| 520 | _aThe present study was conducted on 40 Egyptian chronic active hepatitis C infected patients (CAHC) divided into two groups : Group I (a) , 26 patients of chronic active hepatitis C without cirrhosis and group I (b) , 14 patients of chronic active hepatitis C with cirrhosis The patients were compared to a control group , group II of 15 healthy subjects of matching age and sex Serum MDA (Thiobarbituric chemical method) and ceruloplasmin (Cp) (Nephlometric method) were measured for all patients and controls | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCeruloplasmin (Cp) | |
| 653 | 4 | _aChronic active hepatitis C (CAHC) | |
| 653 | 4 | _aMalondialdehyde (MDA) | |
| 700 | 0 |
_aMarian Fathi Eshak , _eSupervisor |
|
| 700 | 0 |
_aMona Salem Khalil , _eSupervisor |
|
| 700 | 0 |
_aRasha Ahmed Abd El aziz , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAmira _eCataloger |
||
| 905 |
_aEsam _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c31267 _d31267 |
||